rs781036800
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The NM_014000.3(VCL):c.2828_2829del(p.Pro943ArgfsTer9) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000273 in 1,614,194 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000016 ( 0 hom. )
Consequence
VCL
NM_014000.3 frameshift
NM_014000.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.85
Genes affected
VCL (HGNC:12665): (vinculin) Vinculin is a cytoskeletal protein associated with cell-cell and cell-matrix junctions, where it is thought to function as one of several interacting proteins involved in anchoring F-actin to the membrane. Defects in VCL are the cause of cardiomyopathy dilated type 1W. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BS2
High AC in GnomAd4 at 21 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCL | NM_014000.3 | c.2828_2829del | p.Pro943ArgfsTer9 | frameshift_variant | 19/22 | ENST00000211998.10 | NP_054706.1 | |
VCL | NM_003373.4 | c.2746-2193_2746-2192del | intron_variant | NP_003364.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCL | ENST00000211998.10 | c.2828_2829del | p.Pro943ArgfsTer9 | frameshift_variant | 19/22 | 1 | NM_014000.3 | ENSP00000211998 | ||
VCL | ENST00000372755.7 | c.2746-2193_2746-2192del | intron_variant | 1 | ENSP00000361841 | P1 | ||||
VCL | ENST00000623461.3 | n.5549-2193_5549-2192del | intron_variant, non_coding_transcript_variant | 1 | ||||||
VCL | ENST00000624354.3 | c.*2583_*2584del | 3_prime_UTR_variant, NMD_transcript_variant | 18/21 | 2 | ENSP00000485551 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152184Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
20
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251460Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135904
GnomAD3 exomes
AF:
AC:
9
AN:
251460
Hom.:
AF XY:
AC XY:
3
AN XY:
135904
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461892Hom.: 0 AF XY: 0.0000138 AC XY: 10AN XY: 727246
GnomAD4 exome
AF:
AC:
23
AN:
1461892
Hom.:
AF XY:
AC XY:
10
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000138 AC: 21AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74468
GnomAD4 genome
AF:
AC:
21
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Primary dilated cardiomyopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 27, 2015 | The p.Pro943fs variant in VCL has not been previously reported in individuals wi th cardiomyopathy, but has been identified in 5/10406 of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs 781036800). This variant is predicted to cause a frameshift, which alters the pr otein?s amino acid sequence beginning at position 943 and leads to a premature t ermination codon 9 amino acids downstream. Mouse models have shown that loss of function of the VCL gene can lead to DCM (Zemljic-Harpf 2007), although the mode of inheritance associated with such variants in humans is not yet clear. In sum mary, although additional studies are required to fully establish its clinical s ignificance, the p.Pro943fs variant is likely pathogenic. - |
Dilated cardiomyopathy 1W Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 26, 2022 | This sequence change creates a premature translational stop signal (p.Pro943Argfs*9) in the VCL gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in VCL cause disease. This variant is present in population databases (rs781036800, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This premature translational stop signal has been observed in individual(s) with VCL-related conditions (PMID: 26735901, 32516855). ClinVar contains an entry for this variant (Variation ID: 202163). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2022 | Has been reported as a variant of uncertain significance in individuals with DCM (Ware et al., 2016; Hawley et al., 202; Burstein et al., 2021); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; This variant is associated with the following publications: (PMID: 34426522, 33874732, 32746448, 32516855, 26735901) - |
Hypertrophic cardiomyopathy 15 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center of Genomic medicine, Geneva, University Hospital of Geneva | Nov 29, 2016 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 02, 2022 | The c.2828_2829delCT variant, located in coding exon 19 of the VCL gene, results from a deletion of two nucleotides at nucleotide positions 2828 to 2829, causing a translational frameshift with a predicted alternate stop codon (p.P943Rfs*9). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. However, this alteration impacts only one of the two main VCL isoforms (the metavinculin isoform), and loss of function of the metavinculin isoform has not been clearly established as a mechanism of disease. Furthermore, the evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at